This guideline covers managing cataracts in adults aged 18 and over. It aims to improve care before, during and after cataract surgery by optimising service organisation, referral and surgical management, and reducing complications.
Stellaris Elite Vision Enhancement System for the emulsification and removal of cataracts, anterior and posterior segment vitrectomy.
Assorted resources on conditions connected to Ophthalmology.
Bausch Health Companies Inc. and Bausch + Lomb, its leading global eye health business, along with Clearside Biomedical, Inc. announced that the FDA has accepted the re-submitted New Drug Application for Xipere (triamcinolone acetonide suprachoroidal injectable suspension).
Kodiak Sciences Inc., announced topline results from three Phase III studies of tarcocimab tedromer, a novel antibody biopolymer conjugate
Analyses of Phase II and Phase II clinical data show the favorable impact of OMS 302 (ketorolac and phenylephrine), from...
FDA approves the Light Adjustable Lens and Light Delivery Device for post cataract surgery.
In the second of two pivotal Phase III clinical trials evaluating OMS 302, from Omeros Corporation, in patients undergoing intraocular...
Lumacaftor-ivacaftor is indicated for treatment of cystic fibrosis (CF) in patients homozygous for the Phe-508del cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations.